Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Search
No matching results for ''
Tip: Try a valid symbol or a specific company name for relevant results
Mail
Finance Home
News
Market Data
Videos
Industry News
Work & Management
Personal Finance
Brexit
My Portfolio
My Screeners
Watchlists
UK markets closed
FTSE 100
7,015.13
+31.63
(
+0.45%
)
FTSE 250
22,504.62
+32.58
(
+0.14%
)
AIM
1,252.27
+4.14
(
+0.33%
)
Property
UK second homes surge to record high of 495,000
The number of second homes in Britain rose by 30% prior to the pandemic
Aurobindo Pharma Limited (AUROPHARMA.BO)
BSE - BSE Real-time price. Currency in INR
Add to watchlist
953.00
+38.35 (+4.19%)
At close: 3:55PM IST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/03/2020
31/03/2019
31/03/2018
Total revenue
246,296,800
227,379,600
192,259,300
161,992,100
Cost of revenue
105,052,700
102,417,400
92,596,600
71,529,500
Gross profit
141,244,100
124,962,200
99,662,700
90,462,600
Operating expenses
Research development
-
1,217,900
756,300
292,200
Selling general and administrative
-
14,930,200
9,298,200
9,131,000
Total operating expenses
97,010,600
85,546,400
66,578,200
57,788,400
Operating income or loss
44,233,500
39,415,800
33,084,500
32,674,200
Interest expense
699,600
1,416,300
1,507,800
628,900
Income before tax
73,602,600
37,430,400
30,913,500
32,411,800
Income tax expense
19,786,100
9,135,200
7,268,500
8,182,700
Income from continuing operations
53,816,500
28,295,200
23,645,000
24,229,100
Net income
53,831,000
28,309,700
23,647,300
24,231,700
Net income available to common shareholders
53,831,000
28,309,700
23,647,300
24,231,700
Basic EPS
-
48.32
40.36
41.36
Diluted EPS
-
48.32
40.36
41.36
Basic average shares
-
585,931
585,908
585,883
Diluted average shares
-
585,931
585,936
585,888
EBITDA
-
48,513,800
39,100,800
38,620,400
© 2021 Verizon Media. All rights reserved.
Data disclaimer
Help
Suggestions
Privacy Dashboard
Privacy (updated)
About our ads
Terms (updated)